BR100 Increased By (0.85%)
BR30 Increased By (0.42%)
KSE100 Increased By (0.87%)
KSE30 Increased By (0.83%)
AGHA 6.03 Increased By ▲ 0.01 (0.17%)
BECO 3.86 Increased By ▲ 0.05 (1.31%)
BML 61.00 Increased By ▲ 4.56 (8.08%)
BOP 28.09 Decreased By ▼ -0.01 (-0.04%)
CNERGY 11.74 Decreased By ▼ -0.54 (-4.4%)
CSIL 5.30 Increased By ▲ 0.01 (0.19%)
FCCL 54.46 Increased By ▲ 0.65 (1.21%)
FFL 13.07 Increased By ▲ 0.27 (2.11%)
FNEL 1.11 Decreased By ▼ -0.01 (-0.89%)
KEL 5.63 Decreased By ▼ -0.01 (-0.18%)
KOSM 5.34 Decreased By ▼ -0.04 (-0.74%)
LOTCHEM 23.83 Increased By ▲ 0.28 (1.19%)
MLCF 92.98 Increased By ▲ 1.02 (1.11%)
NBP 163.20 Increased By ▲ 0.96 (0.59%)
NCPL 48.27 Decreased By ▼ -0.64 (-1.31%)
NPL 49.71 Decreased By ▼ -0.80 (-1.58%)
OGDC 303.63 Increased By ▲ 1.95 (0.65%)
PACE 8.97 Decreased By ▼ -0.16 (-1.75%)
PAEL 31.91 Increased By ▲ 0.10 (0.31%)
PIBTL 12.74 Decreased By ▼ -0.04 (-0.31%)
PPL 212.91 Increased By ▲ 0.85 (0.4%)
PRL 84.34 Decreased By ▼ -2.92 (-3.35%)
PTC 44.99 Increased By ▲ 1.03 (2.34%)
SSGC 22.83 Decreased By ▼ -0.03 (-0.13%)
TBL 8.88 Decreased By ▼ -0.03 (-0.34%)
TELE 6.50 Increased By ▲ 0.06 (0.93%)
TPL 24.26 Increased By ▲ 0.17 (0.71%)
TPLP 11.99 Decreased By ▼ -0.17 (-1.4%)
TREET 23.14 Decreased By ▼ -0.36 (-1.53%)
TRG 51.47 Decreased By ▼ -0.40 (-0.77%)
World

EU sharpens COVID vaccine export rules as third wave builds

  • The move risks stoking post-Brexit tensions with London, which has warned Brussels against "vaccine nationalism".
  • The granting of export licences will be based on reciprocity and "proportionality" - the epidemiological situation, vaccination rate and access to vaccines in the destination country.
Published Updated
By

BRUSSELS: The European Union refined its rules on the export of COVID-19 vaccines on Wednesday, giving it a clearer right to block shipments to countries such as Britain with higher inoculation rates and to those not exporting their own vaccine doses.

The move risks stoking post-Brexit tensions with London, which has warned Brussels against "vaccine nationalism".

The European Commission, which oversees trade policy for the 27 EU members, set out a proposal expanding on existing measures that seek to ensure planned exports by drugmakers do not threaten reduced EU supply.

The granting of export licences will be based on reciprocity and "proportionality" - the epidemiological situation, vaccination rate and access to vaccines in the destination country.

EU officials say export restrictions could also kick in if companies do respect quarterly contracts but backload supplies at the end of the period.

It will also widen the net to include 17 neighbour countries, including Israel, Norway and Switzerland. Previously exempted, exports to these countries will also need authorisation.

The proposal is set to be a topic of discussion on Thursday at an online summit of EU leaders, whose countries are struggling with a third wave of infections that has prompted harder lockdowns amid a slow roll-out of vaccines.

While France, Germany and Italy broadly support tighter export curbs on those who do not reciprocate, countries including the Netherlands, Belgium and Ireland are more cautious about cutting off Britain.

Irish Prime Minister Micheal Martin said any EU restrictions on vaccine exports would be a "retrograde step".

The Commission insists it is not an export ban and says priority systems set up for vaccinating citizens in other countries are de facto bans even if they are not called so.

"There is not a single country that is targeted, but it is a discussion we begin on reciprocity," an EU official said.

The bloc said it exported 43 million doses to 33 countries since the end of January, including 10.9 million to Britain. Some 380 export requests were granted and only one was blocked - from Italy to Australia.

The EU has so far authorised four COVID-19 vaccines. AstraZeneca doses were supposed to be the vaccination for the masses, but deliveries have and will be far lower than initially indicated.

EU countries have given dose to about 10% of their adult populations and have watched former EU member Britain provide at least one vaccination to over half of all adults, suffering almost no delivery problems, despite the same plants officially supplying both.

The Commission proposal will come into force unless a "qualified majority" of EU members oppose it, which is very unlikely.

Comments

Comments are closed for this article.